These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 38193044

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS).
    Fischer K, Lassila R, Peyvandi F, Gatt A, Gouw SC, Hollingsworth R, Lambert T, Kaczmarek R, Carbonero D, Makris M, European HAemophilia Safety Surveillance (EUHASS) participants.
    Res Pract Thromb Haemost; 2024 May; 8(4):102461. PubMed ID: 39026659
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis.
    Peyvandi F, Cannavò A, Garagiola I, Palla R, Mannucci PM, Rosendaal FR, sippet study group.
    J Thromb Haemost; 2018 Jan; 16(1):39-43. PubMed ID: 29080391
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia a in Italy: Characteristics and Clinical Benefits.
    Schiavoni M, Napolitano M, Giuffrida G, Coluccia A, Siragusa S, Calafiore V, Lassandro G, Giordano P.
    Front Med (Lausanne); 2019 Jan; 6():261. PubMed ID: 31850352
    [Abstract] [Full Text] [Related]

  • 7. No immunological changes after factor VIII product switch: An in depth analysis in haemophilia A patients.
    Schep SJ, Fischer K, Boes M, Schutgens REG.
    Haemophilia; 2023 Jul; 29(4):1039-1048. PubMed ID: 37276354
    [Abstract] [Full Text] [Related]

  • 8. Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review.
    Iorio A, Halimeh S, Holzhauer S, Goldenberg N, Marchesini E, Marcucci M, Young G, Bidlingmaier C, Brandao LR, Ettingshausen CE, Gringeri A, Kenet G, Knöfler R, Kreuz W, Kurnik K, Manner D, Santagostino E, Mannucci PM, Nowak-Göttl U.
    J Thromb Haemost; 2010 Jun; 8(6):1256-65. PubMed ID: 20345722
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical evaluation of a recombinant factor VIII preparation (Kogenate) in previously untreated patients with hemophilia A.
    Yoshioka A, Fukutake K, Takamatsu J, Shirahata A, Kogenate Post-Marketing Surveillance Study Group.
    Int J Hematol; 2003 Dec; 78(5):467-74. PubMed ID: 14704043
    [Abstract] [Full Text] [Related]

  • 18. Optimising prophylaxis outcomes and costs in haemophilia patients switching to recombinant FVIII-Fc: a single-centre real-world experience.
    Tagliaferri A, Matichecchia A, Rivolta GF, Riccardi F, Quintavalle G, Benegiamo A, Rossi R, Coppola A.
    Blood Transfus; 2020 Sep; 18(5):374-385. PubMed ID: 31855153
    [Abstract] [Full Text] [Related]

  • 19. [Factor VIII assays in treated hemophilia A patients].
    Lasne D, Pouplard C, Nougier C, Eschwege V, Le Cam Duchez V, Proulle V, Smahi M, Harzallah I, Voisin S, Toulon P, Sobas F, Galinat H, Flaujac C, Ternisien C, Jeanpierre E, groupe d'études de la biologie des maladies hémorragiques du Groupe français d'études de l'hémostase et la thrombose.
    Ann Biol Clin (Paris); 2019 Feb 01; 77(1):53-65. PubMed ID: 30799298
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.